Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    60 Degrees Pharmaceutical...

    NASDAQ: SXTP · Real-Time Price · USD
    2.92
    -0.04 (-1.35%)
    At close: Jun 06, 2025, 3:59 PM
    2.99
    2.40%
    After-hours: Jun 06, 2025, 05:02 PM EDT

    60 Degrees Pharmaceuticals Statistics

    Share Statistics

    60 Degrees Pharmaceuticals has 1.47M shares outstanding. The number of shares has increased by -39.67% in one year.

    Shares Outstanding

    n/a
    		 1.47M

    Shares Change (YoY)

    n/a
    		 -39.67%

    Shares Change (QoQ)

    n/a
    		 -35.89%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 945

    FTD / Avg. Volume

    n/a
    		 0.06%

    Short Selling Information

    The latest short interest is 32.53K, so 2.21% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 32.53K

    Short % of Shares Out

    n/a
    		 2.21%

    Short % of Float

    n/a
    		 2.25%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.37 and the forward PE ratio is -0.95. 60 Degrees Pharmaceuticals's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.37

    Forward PE

    n/a
    		 -0.95

    PS Ratio

    n/a
    		 4.83

    Forward PS

    n/a
    		 1.2

    PB Ratio

    n/a
    		 0.73

    P/FCF Ratio

    n/a
    		 -0.5

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for 60 Degrees Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 3.25

    Quick Ratio

    n/a
    		 2.98

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 -1227.87

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $202,524.67

    Profits Per Employee

    n/a
    		 $-2,649,035.67

    Employee Count

    n/a
    		 3

    Asset Turnover

    n/a
    		 0.11

    Inventory Turnover

    n/a
    		 0.87

    Taxes

    Income Tax

    n/a
    		 250

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -85.7% in the last 52 weeks. The beta is 2.89, so 60 Degrees Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.89

    52-Week Price Change

    n/a
    		 -85.7%

    50-Day Moving Average

    n/a
    		 2.49

    200-Day Moving Average

    n/a
    		 4.36

    Relative Strength Index (RSI)

    n/a
    		 60.94

    Average Volume (20 Days)

    n/a
    		 1,604,547

    Income Statement

    In the last 12 months, 60 Degrees Pharmaceuticals had revenue of 607.57K and earned -7.95M in profits. Earnings per share was -17.48.

    Revenue

    n/a
    		 607.57K

    Gross Profit

    n/a
    		 222.81K

    Operating Income

    n/a
    		 -9.71M

    Net Income

    n/a
    		 -7.95M

    EBITDA

    n/a
    		 -7.88M

    EBIT

    n/a
    		 -7.95M

    Earnings Per Share (EPS)

    n/a
    		 -17.48
    Full Income Statement

    Balance Sheet

    The company has 1.66M in cash and 155.89K in debt, giving a net cash position of 1.5M.

    Cash & Cash Equivalents

    n/a
    		 1.66M

    Total Debt

    n/a
    		 155.89K

    Net Cash

    n/a
    		 1.5M

    Retained Earnings

    n/a
    		 -40.53M

    Total Assets

    n/a
    		 5.98M

    Working Capital

    n/a
    		 3.85M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -5.65M and capital expenditures -181.11K, giving a free cash flow of -5.83M.

    Operating Cash Flow

    n/a
    		 -5.65M

    Capital Expenditures

    n/a
    		 -181.11K

    Free Cash Flow

    n/a
    		 -5.83M

    FCF Per Share

    n/a
    		 -12.82
    Full Cash Flow Statement

    Margins

    Gross margin is 36.67%, with operating and profit margins of -1598.97% and -1308.01%.

    Gross Margin

    n/a
    		 36.67%

    Operating Margin

    n/a
    		 -1598.97%

    Pretax Margin

    n/a
    		 -1309.37%

    Profit Margin

    n/a
    		 -1308.01%

    EBITDA Margin

    n/a
    		 -1297.58%

    EBIT Margin

    n/a
    		 -1598.97%

    FCF Margin

    n/a
    		 -959.42%

    Dividends & Yields

    SXTP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SXTP is $7, which is 136.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $7

    Price Target Difference

    n/a
    		 136.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Feb 24, 2025. It was a backward split with a ratio of 1:5.

    Last Split Date

    n/a
    		 Feb 24, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:5

    Scores

    Altman Z-Score

    n/a
    		 1.32

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist